Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis

Contact Dermatitis

Volumn 35, Issue 4, 1996, Pages 234-236

  Wolkenstein, Pierre ^a   Chosidow, Olivier ^a   Fléchet, Marie Laure ^a   Robbiola, Odile ^a   Paul, Muriel ^a   Dumé, Laurence ^a   Revuz, Jean ^a   Roujeau, Jean Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Acute generalized exanthematous pustulosis; Antibiotics; Anticonvulsants; Cutaneous adverse drug reactions; Diltiazem; Non steroidal anti inflammatory drugs; Patch tests; Stevens Johnson syndrome; Sulfonamides; Terfenadine; Toxic epidermal necrolysis

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; DILTIAZEM; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE; TERFENADINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATCH TEST; PUSTULOSIS; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 0029952867     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1996.tb02364.x     Document Type: Article

References (14)

1. Roujeau J C, Stern R S. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994: 33: 1272-1285.
2. Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F. Adverse drug reaction monitoring: Doing it the French way. Lancet 1985: 2: 1056-1058.
3. Montgomery P R. Toxic epidermal necrolysis due to phenylbutazone. Br J Dermatol 1970: 83: 220.
4. Friedmann P S, Strickland I, Pirmohamed M, Park K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994: 130: 598-604.
5. Tagami H, Tatsuta K, Iwatski K, Yamada M. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol 1983: 119: 910-913.
6. Roujeau J C, Chosidow O, Saiag Ph, Guillaume J C. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990: 23: 1039-1057.
7. Roujeau J C, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991: 127: 1333-1338.
8. Alanko C. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993: 29: 254-257.
9. Bruynzeel D P, Van-Ketel W G. Patch testing in drug eruptions. Semin Dermatol 1989;: 8: 196-203.
10. Houwerzijl J, Gast G D, Nater J, Esselink T, Nieweg H. Lymphocyte-stimulation tests and patch tests in carbamazepine hypersensitivity. Clin Exp Immunol 1977: 29: 272-277.
11. Alanko C. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993: 29: 254-257.
12. Calkin J M, Maibach H I. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993: 29: 223-233.
13. Osawa J, Naito S, Aihara M et al. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 1990: 17: 235-239.
14. Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 198: ; 125: 299.